The COVID-19 Antigen Test Kit is for in vitro diagnostic use only for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in human throat swab and nasal swab specimens from individuals with suspected COVID-19.

The results are for the identification of the SARS CoV-2 nucleocapsid protein antigen. The antigen is usually detectable on anterior nasal (nasal) swabs during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is required to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The detected agent may not be the exact cause of the disease.

Negative results should be evaluated in the context of a patient's recent exposure, history, and presence of clinical signs and symptoms consistent with COVID-19.

The Invamed Covid-19 Detector kit contains all the necessary components to perform a test for SARS-CoV-2. Currently, patients infected by the new coronavirus are the main source of infection; Asymptomatic infected persons can also be a source of infection. According to current epidemiological research, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms are fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia, and diarrhea occur in a few cases. The antigen is usually detectable in upper respiratory tract specimens during the acute phase of infection. Rapid diagnosis of SARS-CoV-2 infection will help healthcare professionals treat patients and control the disease more efficiently and effectively.